Enterprise Value

-64.79M

Cash

135.7M

Avg Qtr Burn

-19.75M

Short % of Float

1.74%

Insider Ownership

20.39%

Institutional Own.

60.53%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ALG-055009 (THR-β Agonist) Details
Non-alcoholic steatohepatitis

Phase 2a

Data readout

Phase 1

Data readout

Phase 1

Data readout

Failed

Discontinued

ALG-125755 Details
Chronic hepatitis B, Liver disease

Failed

Discontinued